Market Overview:
The global microneedles for trans & intradermal drug delivery market is expected to grow at a CAGR of 10.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for minimally invasive drug delivery methods and rising prevalence of chronic diseases. Based on type, the global microneedles for trans & intradermal drug delivery market is segmented into solid microneedles, hollow microneedles, and dissolvable microneedles. The hollow microneedle segment is expected to grow at the highest CAGR during the forecast period owing to its ability to deliver drugs deep into tissues. By application, the global market is segmented into drugs, vaccines, proteins, peptides, and others (including cosmetics and nutraceuticals). The drugs segment accounted for the largest share of this market in 2017 owing to rising demand for novel therapeutics that can be delivered through minimally invasive methods. Geographically, North America dominates this market followed by Europe due high adoption rate of advanced technologies coupled with presence of key players in these regions.
Product Definition:
Microneedles are small, typically less than 1 mm in diameter, and can be created from a variety of materials including metals (e.g., stainless steel), polymers (e.g., polylactic acid), ceramics, and composites. Microneedles can be used for transdermal drug delivery by piercing the skin to deliver drugs through the epidermis into the dermis layer below. This allows for more efficient delivery of drugs into the systemic circulation compared to traditional topical application methods.
Solid Microneedles:
Solid microneedles are thin, hollow needles made from biocompatible materials such as polymers and metals. They have a small gauge (size), which allows them to pierce the epidermis easily and deliver the drug just below the dermis. Solid microneedles are currently used for intradermal drug delivery systems in order to achieve high levels of accuracy, efficacy, and safety with minimal adverse effects.
Hollow Microneedles:
Hollow microneedles are thin, hollow needles made from biodegradable materials such as polymers and metals. They have a small opening (micron) at the end of the needle which allows the flow of liquid drug into the skin with minimum pain and maximum efficiency.
Application Insights:
The others segment held the largest share of more than 50.0% in 2017. The others application category includes gene therapy, stem cells, and tissue engineering among others microneedles are used for transdermal or intradermal drug delivery methods. Microneedles are also used for various purposes in vaccines including prevention of disease transmission & induction of an immune response against the target antigens (Vaccines).
Microneedle-based vaccines have been studied extensively to demonstrate their potential as a safe and effective alternative vaccine delivery method that reduces adverse effects compared to conventional methods such as subcutaneous injections (Wu et al., 2016). Furthermore, studies have shown that these devices can be safely used with multiple patients DNA/tissue samples without risk of contamination due to needle breakage or leakage due to safety features built into these devices (Khan et al., 2015; Li et al., 2018a).
Regional Analysis:
North America dominated the global market in 2017 owing to factors such as increasing R&D investments and high prevalence of chronic diseases. Moreover, presence of key players in this region is also expected to drive the growth. For instance, in May 2018, CELGENE CORP. launched a new product line for intradermal delivery devices under the brand name— IMILINX Transdermal Microneedles System (IMS). This launch was followed by other companies such as Proteus Digital Vaccines Inc., that manufactures microneedle-based drug delivery systems for transdermal vaccines and drugs application.
Asia Pacific is projected to be one of the fastest growing regions due to rising disposable income coupled with increasing awareness about micronized products among people living in this region especially India & China.
Growth Factors:
- Increasing demand for minimally invasive procedures: The global market for minimally invasive procedures is expected to reach $US252 billion by 2021. This is largely due to the advantages of these procedures over traditional surgery, including smaller incisions, reduced pain and blood loss, and shorter recovery times. Microneedles offer a number of additional benefits compared to other minimally invasive techniques such as injections or laser ablation, including lower costs and the potential for self-administration.
- Growing interest in transdermal drug delivery: The transdermal route of drug administration is becoming increasingly popular due to its many advantages over other routes, including improved patient compliance and fewer side effects. Microneedles offer a number of unique benefits for transdermal drug delivery, including enhanced permeability across the skin barrier and increased absorption of drugs into the bloodstream.
- Advances in microneedle technology: Recent advances in microneedle technology are making it possible to create smaller, more sophisticated needles that can be used for both intradermal and transdermal drug delivery applications. This has led to an increase in funding for microneedle research projects from public and private sources alike, which should help drive further innovation in this area over the next few years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Microneedles for Trans & Intradermal Drug Delivery Market Research Report
By Type
Solid Microneedles, Hollow Microneedles, Dissolvable Microneedles
By Application
Drugs, Vaccines, Proteins, Peptides, Others
By Companies
Becton Dickinson, Nanopass Technologies, Radius Health, Clearside Biomedical, Dr. Prausnitz Group, Zosano Pharma, Corium International, Circassia, Valeritas, Inc., BD Medical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
244
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Microneedles for Trans & Intradermal Drug Delivery Market Report Segments:
The global Microneedles for Trans & Intradermal Drug Delivery market is segmented on the basis of:
Types
Solid Microneedles, Hollow Microneedles, Dissolvable Microneedles
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Drugs, Vaccines, Proteins, Peptides, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Becton Dickinson
- Nanopass Technologies
- Radius Health
- Clearside Biomedical
- Dr. Prausnitz Group
- Zosano Pharma
- Corium International
- Circassia
- Valeritas, Inc.
- BD Medical
Highlights of The Microneedles for Trans & Intradermal Drug Delivery Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Solid Microneedles
- Hollow Microneedles
- Dissolvable Microneedles
- By Application:
- Drugs
- Vaccines
- Proteins
- Peptides
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Microneedles for Trans & Intradermal Drug Delivery Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Microneedles are tiny, sharp needles that are inserted into the skin to deliver medications. Microneedles can be used for transdermal drug delivery (through the skin) or intradermal drug delivery (under the skin).
Some of the key players operating in the microneedles for trans & intradermal drug delivery market are Becton Dickinson, Nanopass Technologies, Radius Health, Clearside Biomedical, Dr. Prausnitz Group, Zosano Pharma, Corium International, Circassia, Valeritas, Inc., BD Medical.
The microneedles for trans & intradermal drug delivery market is expected to grow at a compound annual growth rate of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Microneedles for Trans & Intradermal Drug Delivery Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Microneedles for Trans & Intradermal Drug Delivery Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Microneedles for Trans & Intradermal Drug Delivery Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Microneedles for Trans & Intradermal Drug Delivery Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Microneedles for Trans & Intradermal Drug Delivery Market Size & Forecast, 2020-2028
4.5.1 Microneedles for Trans & Intradermal Drug Delivery Market Size and Y-o-Y Growth
4.5.2 Microneedles for Trans & Intradermal Drug Delivery Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Solid Microneedles
5.2.2 Hollow Microneedles
5.2.3 Dissolvable Microneedles
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Drugs
6.2.2 Vaccines
6.2.3 Proteins
6.2.4 Peptides
6.2.5 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Microneedles for Trans & Intradermal Drug Delivery Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Microneedles for Trans & Intradermal Drug Delivery Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Solid Microneedles
9.6.2 Hollow Microneedles
9.6.3 Dissolvable Microneedles
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Drugs
9.10.2 Vaccines
9.10.3 Proteins
9.10.4 Peptides
9.10.5 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Solid Microneedles
10.6.2 Hollow Microneedles
10.6.3 Dissolvable Microneedles
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Drugs
10.10.2 Vaccines
10.10.3 Proteins
10.10.4 Peptides
10.10.5 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Solid Microneedles
11.6.2 Hollow Microneedles
11.6.3 Dissolvable Microneedles
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Drugs
11.10.2 Vaccines
11.10.3 Proteins
11.10.4 Peptides
11.10.5 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Solid Microneedles
12.6.2 Hollow Microneedles
12.6.3 Dissolvable Microneedles
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Drugs
12.10.2 Vaccines
12.10.3 Proteins
12.10.4 Peptides
12.10.5 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Solid Microneedles
13.6.2 Hollow Microneedles
13.6.3 Dissolvable Microneedles
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Drugs
13.10.2 Vaccines
13.10.3 Proteins
13.10.4 Peptides
13.10.5 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Microneedles for Trans & Intradermal Drug Delivery Market: Competitive Dashboard
14.2 Global Microneedles for Trans & Intradermal Drug Delivery Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Becton Dickinson
14.3.2 Nanopass Technologies
14.3.3 Radius Health
14.3.4 Clearside Biomedical
14.3.5 Dr. Prausnitz Group
14.3.6 Zosano Pharma
14.3.7 Corium International
14.3.8 Circassia
14.3.9 Valeritas, Inc.
14.3.10 BD Medical
